Russian chemical industry to take a hit

The Russian chemical industry looks set for a serious crisis, as the country’s flagship chemical producer, Khimprom, faces liquidation. The closure could have a knock-on effect on other Russian producers.

Rostec, a Russian state corporation (established to promote, develop, produce and export hi-tech industrial products for the civil and defense sectors) and the majority shareholder of Khimprom, says that the enterprise will completely cease its operations by March 2015 and will be liquidated by May 2016. Of the 5000 workers Khimprom currently employs, about 4000 will be laid off.

Decaying chemical plant

Khimprom is Russia's flagship chemical producer and sole supplier of some products; its closure could have wide-reaching effects © Shutterstock

Khimprom is being closed down because it is no longer profitable. The company declared bankruptcy in November 2012, as its debts exceeded RUB10 billion (£169 million).

According to an official Rostec representative, the company was hampered by high energy prices; outdated technology; depreciation of equipment, which reached 95%; as well as unsuccessful competition with foreign rivals.

Rostec is working with the Russian government to solve the most pressing issues, in particular the fate of Khimprom’s workers. There are several options, including transferring some employees to other Rostec enterprises, but no final decision has yet been taken.

Analysts from the Russian Ministry of Industry and Trade believe that liquidating Khimprom, which currently produces a wide range of chemical products, may result in a serious crisis in the Russian chemical industry. The company remains the only Russian producer of calcium carbide, emulsion PVC, perchloroethylene and some other products, and its closure may lead to market shortages of some of these products.

Cutting off supplies

Khimprom’s key customers are mainly law enforcement agencies, as well as Russia’s Defense Ministry and Federal Security Service, which purchase components for manufacturing body armor and tear gas, as well as Khimprom’s branded disinfectant Volgotab. Cutting supplies of these products to the Russian army could be bad news for the Russian Ministry of Defence.

Andrei Kostin, chief editor of Rupec – Russia’s leading chemistry and petrochemicals magazine – believes that closing the enterprise may also lead to crisis in the Russian speciality chemicals sector. Khimprom currently accounts for almost half of the Russian manufacture of dichloroethane, and 20% of the domestic production of liquid chlorinated paraffin. The company is also the sole Russian producer of about ten chemicals, in particular chlorine bleach. Withdrawing supplies of these products would result in price increases, Kostin suggests.

Closing Khimprom would also disrupt military chemical waste disposal waste, which previously was one of its primary spheres of activity.

Related Content

Problems for Russian chemicals?

25 October 2012 Business

news image

Accession to WTO will force government to ditch badly needed subsidies

Russia pays high scientific price over Ukraine

7 May 2014 News and Analysis

news image

US bans Russian scientists visiting energy labs and Nasa with Russia threatening tit-for-tat response

Most Read

Coated nanoparticles show Alzheimer's promise

12 September 2014 News and Analysis

news image

Gold nanoparticles functionalised with amino acid polymer inhibit the growth of amyloid fibres associated with neurodegenerat...

Computer simulations point to formamide as prebiotic intermediate in ‘Miller’ mixtures

16 September 2014 News and Analysis

news image

Electric field may have provided more than just energy for primordial chemistry

Most Commented

US genomics lead being lost to China

17 September 2014 News and Analysis

news image

NIH senior leaders are sounding the alarm bells, saying the US's pre-eminence in genomics research is under threat

The trouble with boycotts

29 August 2014 Critical Point

news image

Cutting academic ties with a censured state can do more harm than good, says Mark Peplow